Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Fred Levine who wrote (925)	8/10/1999 5:03:00 PM
From: caly	Read Replies (1) of 2515

Post from Yahoo... Spoke to IMCL by: pharmainvestor11 2480 of 2480 SUMMARY 1. Neck & head cancer · C225 + radiation (416 patients) PH3 completion in 3Q 00 · C225 + drug (forgot it name) PH3 completion in 4Q 00 · For both IMCL will get an outside house to review the results · NDA filing (their timetable) 2Q 01 2. Other cancers In 2H 99 will start PH2 for pancreatic, colon, and non-small cell lungs cancers 3. No conference presentations are scheduled in 99. 4. There is no "poison pill" against takeover. Therefore, in the next 5-8 months will be no news and a lot of speculations! Pharma

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next